Literature DB >> 35926981

Searching for the Risk-Benefit Profile of Higher Potassium Intake in CKD: Primum Non Nocere.

Murilo Guedes1, Roberto Pecoits-Filho2,3.   

Abstract

Entities:  

Keywords:  chronic kidney disease; hyperkalemia; potassium

Year:  2022        PMID： 35926981      PMCID： PMC9529186          DOI： 10.1681/ASN.2022060695

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  10 in total

1.  Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Catherine M Clase; Juan-Jesus Carrero; David H Ellison; Morgan E Grams; Brenda R Hemmelgarn; Meg J Jardine; Csaba P Kovesdy; Gregory A Kline; Gregor Lindner; Gregorio T Obrador; Biff F Palmer; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Roberto Pecoits-Filho
Journal:  Kidney Int       Date:  2019-10-10       Impact factor: 10.612

Review 2.  Hyperkalemia in patients with chronic renal failure.

Authors:  Stephen L Seliger
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 5.992

3.  Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease?

Authors:  Christiane I Ramos; Ailema González-Ortiz; Angeles Espinosa-Cuevas; Carla M Avesani; Juan Jesus Carrero; Lilian Cuppari
Journal:  Nephrol Dial Transplant       Date:  2021-11-09       Impact factor: 5.992

Review 4.  Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet? A Cautionary Tale.

Authors:  David E St-Jules; Deborah J Clegg; Biff F Palmer; Juan-Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-20       Impact factor: 8.237

5.  Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Authors:  Martin Gritter; Rosa D Wouda; Stanley M H Yeung; Michiel L A Wieërs; Frank Geurts; Maria A J de Ridder; Christian R B Ramakers; Liffert Vogt; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2022-05-24       Impact factor: 14.978

6.  Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.

Authors:  Joy M Weinberg; Lawrence J Appel; George Bakris; Jennifer J Gassman; Tom Greene; Cynthia A Kendrick; Xuelei Wang; James Lash; Julia A Lewis; Velvie Pogue; Denyse Thornley-Brown; Robert A Phillips
Journal:  Arch Intern Med       Date:  2009-09-28

7.  Randomized, Controlled Trial of the Effect of Dietary Potassium Restriction on Nerve Function in CKD.

Authors:  Ria Arnold; Timothy J Pianta; Bruce A Pussell; Adrienne Kirby; Kate O'Brien; Karen Sullivan; Margaret Holyday; Christine Cormack; Matthew C Kiernan; Arun V Krishnan
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-11       Impact factor: 8.237

8.  Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Authors:  Martin Gritter; Liffert Vogt; Stanley M H Yeung; Rosa D Wouda; Christian R B Ramakers; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  Nephron       Date:  2018-06-29       Impact factor: 2.847

9.  Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Peter Rossing; Peter Kolkhof; Christina Nowack; Patrick Schloemer; Amer Joseph; Gerasimos Filippatos
Journal:  N Engl J Med       Date:  2020-10-23       Impact factor: 91.245

Review 10.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses.

Authors:  Nancy J Aburto; Sara Hanson; Hialy Gutierrez; Lee Hooper; Paul Elliott; Francesco P Cappuccio
Journal:  BMJ       Date:  2013-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.